HLAA’s Externally-Led Patient-Focused Drug Development (PFDD) Meeting FAQs

Tuesday, May 25, 2021, 10 a.m.-3 p.m. (U.S. ET)


What is this meeting? What does it mean?

The Hearing Loss Association of America (HLAA) received permission from the U.S. Food & Drug Administration (FDA) to hold an Externally-Led Patient-Focused Drug Development Meeting for People and Families Living with Sensorineural Hearing Loss on Tuesday, May 25, from 10 a.m.-3 p.m. (U.S. ET).

This meeting represents the voice of the person with hearing loss. Two panels will speak about their experiences living with hearing loss. Meeting attendees will have the opportunity to call in and submit online written comments about the issues discussed during the meeting. All meeting comments collected before, during and in the 30 days following the meeting will be included in a “Voice of the Patient” report to be published a few months after the meeting.

People can participate live the day of the meeting or send in questions and comments ahead of time here. You may join part of the live meeting if your schedule allows for that; you can come in and out of the live meeting. If you cannot join the live meeting, we encourage you to view the meeting recording, which will be available on May 27, 2021.